Trastuzumab and breast cancer.
作者信息
Strasser F, Betticher D C, Suter T M
出版信息
N Engl J Med. 2001 Sep 27;345(13):996.
PMID:11575296
Abstract
摘要
相似文献
1
Trastuzumab and breast cancer.
N Engl J Med. 2001 Sep 27;345(13):996.
2
Trastuzumab cardiac side effects: only time will tell.曲妥珠单抗的心脏副作用：只有时间能给出答案。
J Clin Oncol. 2005 Nov 1;23(31):7775-6. doi: 10.1200/JCO.2005.04.1558.
3
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31.在一项随机试验中评估心脏功能障碍，该试验比较了多柔比星联合环磷酰胺后序贯紫杉醇，联合或不联合曲妥珠单抗作为淋巴结阳性、人表皮生长因子受体2过表达乳腺癌的辅助治疗：NSABP B - 31。
J Clin Oncol. 2005 Nov 1;23(31):7811-9. doi: 10.1200/JCO.2005.02.4091.
4
Troponin I as a predictor for trastuzumab-related cardiotoxicity: current data do not provide mechanistic insights or allow for incorporation into clinical practice.
J Clin Oncol. 2011 Mar 1;29(7):e175-6. doi: 10.1200/JCO.2010.32.7353. Epub 2010 Dec 28.
5
Irreversible cardiotoxicity after adjuvant treatment with trastuzumab in a case of breast cancer.
Tumori. 2008 Sep-Oct;94(5):777-8. doi: 10.1177/030089160809400527.
6
Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment.曲妥珠单抗相关心脏毒性的可逆性：基于临床病程和药物治疗反应的新见解
J Clin Oncol. 2005 Nov 1;23(31):7820-6. doi: 10.1200/JCO.2005.13.300.
7
Trastuzumab-induced cardiac dysfunction.曲妥珠单抗诱导的心脏功能障碍。
Nucl Med Commun. 2007 Feb;28(2):69-73. doi: 10.1097/MNM.0b013e328025ae04.
8
Trastuzumab and breast cancer.曲妥珠单抗与乳腺癌。
N Engl J Med. 2001 Sep 27;345(13):996-7.
9
Can modern echocardiographic techniques predict drug-induced cardiotoxicity?现代超声心动图技术能否预测药物性心脏毒性？
J Am Coll Cardiol. 2011 May 31;57(22):2271-2. doi: 10.1016/j.jacc.2010.11.064.
10
HER2-positive breast cancer: current treatment strategies.人表皮生长因子受体2阳性乳腺癌：当前的治疗策略
Cancer Invest. 2008 Jul;26(6):545-52. doi: 10.1080/07357900801971024.
引用本文的文献
1
Cardiac toxicity with anti-HER-2 therapies: what have we learned so far?抗HER-2治疗的心脏毒性：我们目前了解到了什么？
Target Oncol. 2009 Apr;4(2):77-88. doi: 10.1007/s11523-009-0112-2. Epub 2009 May 6.
2
Naturally occurring B-cell responses to breast cancer.对乳腺癌的天然B细胞反应。
Cancer Immunol Immunother. 2003 Dec;52(12):715-38. doi: 10.1007/s00262-003-0409-4. Epub 2003 Aug 15.
Zotero 插件